Ultimovacs AB
559144-3162ActivePioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
Oversikt
- 0
- Ansatte
- 5–10mill SEK
- Omsetning
- 2018
- Grunnlagt
Nøkkelbeslutningstakere
Namir Hassan
CEO
Beskrivelse
Zelluna is a biotechnology company dedicated to pioneering novel cell therapies for the treatment of cancer patients. Their core mission is to eliminate solid cancers by developing T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK. This proprietary platform aims to ove...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559144316201
Beslutningstakere
1 kontakter i FunnelfeedrNamir Hassan
CEO
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
ZELLUNA IMMUNOTHERAPY AS
9 ansattePioneering TCR-NK cell therapies to eliminate solid cancers safely.
ZELLUNA ASA
8 ansattePioneering TCR-NK cell therapies to eliminate solid cancers effectively.
CuraCell Holding AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
CANTARGIA AB
20–49 ansatteDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
BIO INVENTION AS
Clinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Utforsk mer
Spørsmål om Ultimovacs AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo